SOFRADIM PRODUCTION SAS MESH SOFRADIM - PARIETEX¿ COMPOSITE MESH MESH, SURGICAL, POLYMERIC
|
Back to Search Results |
|
Model Number PCO3020 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Adhesion(s) (1695); Bacterial Infection (1735); Unspecified Infection (1930); Pain (1994); Staphylococcus Aureus (2058); Hernia (2240); Injury (2348); Impaired Healing (2378); Unspecified Tissue Injury (4559)
|
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of a hernia.
It was reported that after implant, the patient experienced adhesions, infection, and recurrence.
Treatment provided for these conditions include mesh removal.
|
|
Event Description
|
The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of an incisional hernia.
It was reported that after underlay implant, the patient experienced adhesions, infection, open wound, mrsa, chronic pain, exposed mesh and recurrence.
Post-operative patient treatment included revision surgery, mesh removal, rives-stoppa repair with release of posterior sheath and transversus abdominis musculature, two bilateral muscle advancements, myofascial advancement of rectus muscle to midline for closure of hernia and placement of retrorectus mesh, finally debridement of skin and primary closure and lysis of adhesions.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
This information was received as a part of an extensive mesh litigation submission to medtronic.
The fda was notified of this large complaint receipt.
Due to the volume of complaint information received by medtronic, this resulted in a report beyond the 30 day target.
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of an inguinal hernia.
It was reported that after implant, the patient experienced adhesions, infection, open wound, and recurrence.
Post-operative patient treatment included revision surgery, mesh removal, and lysis of adhesions.
|
|
Event Description
|
The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of an incisional hernia.
It was reported that after underlay implant, the patient experienced adhesions, infection, open wound, mrsa, and recurrence.
Post-operative patient treatment included revision surgery, mesh removal, rives-stoppa repair with release of posterior sheath and transversus abdominis musculature, two bilateral muscle advancements, myofascial advancement of rectus muscle to midline for closure of hernia and placement of retrorectus mesh, finally debridement of skin and primary closure and lysis of adhesions.
|
|
Manufacturer Narrative
|
This information was received as a part of an extensive mesh litigation submission to medtronic.
The fda was notified of this large complaint receipt.
Due to the volume of complaint information received by medtronic, this resulted in a report beyond the 30 day target.
If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|